Delivery Order SPE2DB22D2206-SPE2DB25FEE29
Award Date
11/12/24
Potential Completion Date
12/4/24
Potential Value
$5.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,631.84, is for the delivery of Zoladex 10.8 mg implant syringes. The contract is a Firm Fixed Price Delivery Order and has an ultimate completion date of July 11, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,859.50, is for the delivery of the drug Zoladex 10.8 mg Implant Syringe. The contract has a completion date of June 5, 2025 and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp is the prime contractor, and the contract does not have a set-aside designation, indicating open competition. This award is part of a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,789.25, is for the delivery of Zoladex 10.8 mg implant syringes, a medication used for the treatment of certain medical conditions. The contract is a firm fixed-price delivery order, with a performance period ending on May 6, 2025. Amerisourcebergen Drug Corp is the prime contractor, and...
This federal contract award is for the delivery of the pharmaceutical product Zoladex 10.8 mg implant syringes to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 6, 2024, with a potential ceiling value of $5,445.66. The contract has a firm fixed-price delivery order structure and an ultimate completion date of December 30, 2024. AmerisourceBergen...
This federal contract award is for the delivery of Zoladex 10.8 mg implant syringes to the Defense Logistics Agency (DLA). The contract, valued at $16,919.60, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed-price pricing type and an ultimate completion date of February 9, 2023. While the original solicitation was not provided, the award indicates that no set-aside was used, suggesting open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Zoladex 10.8 mg implant syringes. The fixed-price delivery order, valued at $2,537.94, has a completion date of May 3, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award SPE2DB22D2206|SPE2DB24FJL31 was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Zoladex 10.8 mg implant syringes. The $5,263.74 firm fixed-price delivery order has an ultimate completion date of August 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $7,018.24 Firm Fixed Price Delivery Order is for the supply of the medication Zoladex 10.8 mg Implant Syringes. The contract has an ultimate completion date of May 14, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to Amerisourcebergen Drug Corporation's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, which is not set-aside, provides for the delivery of Zoladex 3.6 mg implant syringes at a firm fixed price of $3,122.90. The award date is October 11, 2024, and the ultimate completion date is November 4, 2024. Amerisourcebergen...
This federal contract award, valued at $20,303.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, a specialized medical product, with a completion date of September 18, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...